Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
SEC Form 4 Filing
Director Steve Krognes reported the vesting of restricted stock units and subsequent acquisition of common stock in Guardant Health, Inc.
Summary
- On March 31, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- 154 restricted stock units vested, converting into 154 shares of common stock.
- Following the transaction, Krognes directly owns 3,239 shares of common stock and 4,166 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions, with no inherent positive or negative sentiment.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it's a routine vesting of previously granted equity.
Key Dates
| Date | Description |
|---|---|
| 08/09/2022 | Date of restricted stock unit award grant. |
| 06/30/2023 | First vesting date of the restricted stock unit award (25%). |
| 03/31/2024 | Date of the reported transaction: vesting of 154 restricted stock units. |
| 04/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.